Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Irinotecan × Clear all

Sponsor

Conditions

Colorectal Neoplasms 70 Colonic Neoplasms 27 Rectal Neoplasms 26 Esophageal Neoplasms 20 Stomach Neoplasms 19 Neoplasms 19 Pancreatic Neoplasms 17 Neoplasm Metastasis 15 Neuroblastoma 11 Glioma 10 Glioblastoma 9 Sarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Brain Neoplasms 8 Adenocarcinoma Of Esophagus 8 Rhabdomyosarcoma 7 Small Cell Lung Carcinoma 6 Sarcoma, Ewing 6 Gliosarcoma 6 Esophageal Squamous Cell Carcinoma 6 Lung Neoplasms 5 Medulloblastoma 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Central Nervous System Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Diseases 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Oligodendroglioma 3

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡